Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Fenner

Showing results (131-140 of 138) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 138 results.
Nature Immunology|November 29, 2005
Suppressor of cytokine signaling 1 regulates the immune response to infection by a unique inhibition of type I interferon activityJennifer E Fenner, Robyn Starr, Ann L Cornish, et al.
Obstetrics and Gynecology|February 3, 2007
Comparison of levator ani muscle defects and function in women with and without pelvic organ prolapseJohn O L DeLancey, Daniel M Morgan, Dee E Fenner, et al.
Nature Immunology|January 18, 2006
Suppressor of cytokine signaling 1 negatively regulates Toll-like receptor signaling by mediating Mal degradationAshley Mansell, Rosealee Smith, Sarah L Doyle, et al.
Bioorganic & Medicinal Chemistry Letters|January 18, 2015
The discovery of 1,2,3,9b-tetrahydro-5H-imidazo[2,1-a]isoindol-5-ones as a new class of respiratory syncytial virus (RSV) fusion inhibitors. Part 1Silas Bond, Alistair G Draffan, Jennifer E Fenner, et al.
Sexually Transmitted Diseases|April 1, 1999
Comparison of once-daily and twice-daily dosing of 0.75% metronidazole gel in the treatment of bacterial vaginosisC H Livengood, D E Soper, K L Sheehan, et al.
Bioorganic & Medicinal Chemistry Letters|January 18, 2015
1,2,3,9b-Tetrahydro-5H-imidazo[2,1-a]isoindol-5-ones as a new class of respiratory syncytial virus (RSV) fusion inhibitors. Part 2: identification of BTA9881 as a preclinical candidateSilas Bond, Alistair G Draffan, Jennifer E Fenner, et al.
Cell|September 18, 1999
SOCS1 is a critical inhibitor of interferon gamma signaling and prevents the potentially fatal neonatal actions of this cytokineW S Alexander, R Starr, J E Fenner, et al.
Cancer Discovery|April 29, 2024
Molecular Determinants of Sensitivity to Polatuzumab Vedotin in Diffuse Large B-Cell LymphomaSean R Corcoran, James D Phelan, Jaewoo Choi, et al.
Pageof 14

Showing results (131-140 of 138) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 138 results.
Nature Immunology|November 29, 2005
Suppressor of cytokine signaling 1 regulates the immune response to infection by a unique inhibition of type I interferon activityJennifer E Fenner, Robyn Starr, Ann L Cornish, et al.
Obstetrics and Gynecology|February 3, 2007
Comparison of levator ani muscle defects and function in women with and without pelvic organ prolapseJohn O L DeLancey, Daniel M Morgan, Dee E Fenner, et al.
Nature Immunology|January 18, 2006
Suppressor of cytokine signaling 1 negatively regulates Toll-like receptor signaling by mediating Mal degradationAshley Mansell, Rosealee Smith, Sarah L Doyle, et al.
Bioorganic & Medicinal Chemistry Letters|January 18, 2015
The discovery of 1,2,3,9b-tetrahydro-5H-imidazo[2,1-a]isoindol-5-ones as a new class of respiratory syncytial virus (RSV) fusion inhibitors. Part 1Silas Bond, Alistair G Draffan, Jennifer E Fenner, et al.
Sexually Transmitted Diseases|April 1, 1999
Comparison of once-daily and twice-daily dosing of 0.75% metronidazole gel in the treatment of bacterial vaginosisC H Livengood, D E Soper, K L Sheehan, et al.
Bioorganic & Medicinal Chemistry Letters|January 18, 2015
1,2,3,9b-Tetrahydro-5H-imidazo[2,1-a]isoindol-5-ones as a new class of respiratory syncytial virus (RSV) fusion inhibitors. Part 2: identification of BTA9881 as a preclinical candidateSilas Bond, Alistair G Draffan, Jennifer E Fenner, et al.
Cell|September 18, 1999
SOCS1 is a critical inhibitor of interferon gamma signaling and prevents the potentially fatal neonatal actions of this cytokineW S Alexander, R Starr, J E Fenner, et al.
Cancer Discovery|April 29, 2024
Molecular Determinants of Sensitivity to Polatuzumab Vedotin in Diffuse Large B-Cell LymphomaSean R Corcoran, James D Phelan, Jaewoo Choi, et al.
Pageof 14